Difficulty: Medium
Average Score: 75%
Practice
Long-term control medications of chronic bronchial asthma include the following drugs EXCEPT:
Correct answer
D
Rationale
In the treatment of chronic bronchial asthma, long-term control medications play a crucial role in managing symptoms and preventing exacerbations. The correct answer is D) ╬▓-adrenergic antagonists like pindolol. The rationale behind this is that ╬▓-adrenergic antagonists can actually worsen asthma symptoms by blocking the action of ╬▓2 receptors in the bronchial smooth muscle, leading to bronchoconstriction.
Option A, Selective long-acting B2-agonists (LABA) like salmeterol, is a valid long-term control medication as they stimulate ╬▓2 receptors, causing bronchodilation. Option B, Slow-release theophylline, is also a long-term control medication that helps relax the airway smooth muscles. Option C, Inhaled corticosteroids like budesonide, are essential in chronic asthma management as they reduce airway inflammation.
Educationally, understanding the mechanism of action of each drug is vital for healthcare providers to appropriately select the most effective treatment for patients with chronic bronchial asthma. It is crucial to differentiate between medications that can provide long-term control and those that may exacerbate symptoms to optimize patient outcomes and quality of life.
Option A, Selective long-acting B2-agonists (LABA) like salmeterol, is a valid long-term control medication as they stimulate ╬▓2 receptors, causing bronchodilation. Option B, Slow-release theophylline, is also a long-term control medication that helps relax the airway smooth muscles. Option C, Inhaled corticosteroids like budesonide, are essential in chronic asthma management as they reduce airway inflammation.
Educationally, understanding the mechanism of action of each drug is vital for healthcare providers to appropriately select the most effective treatment for patients with chronic bronchial asthma. It is crucial to differentiate between medications that can provide long-term control and those that may exacerbate symptoms to optimize patient outcomes and quality of life.